SmartRent Q1 2026 Earnings EPS Miss as Stock Rises 492 on Strategic Progress LITE Q1 2026 Earnings EPS Beats Estimates Revenue Impact Unclear Stock Down 182 NewAmsterdam Pharma NAMS Q1 2026 Earnings EPS Beat Reflects Cost Management Amid PreRevenue Phase AARD Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Focuses on Pipeline Progress NTRA Q1 2026 Earnings WiderthanExpected Loss Weighs on Shares TPST Q1 2026 Earnings Significant EPS Miss as PreRevenue Biotech Continues RD Investment